インディアナ州における動脈硬化の臨床試験
インディアナ州内の拠点で、動脈硬化に関する8件の研究が参加者を募集しています。
インディアナ州内の都市
公式研究テキスト(英語)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/30更新 · NCT07783802A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
- Asha Clinical Research-Munster,Llc, Hammond
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/29更新 · NCT07448038Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- IU Health Bloomington, Bloomington
- Indiana University Health Methodist Hospital, Indianapolis
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/24更新 · NCT07157774Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Cardiovascular Research of Northwest Indiana LLC, Munster
- Velocity Clinical Research - Valparaiso, Valparaiso
被験者募集中第3相
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
- NANI Research, Fort Wayne
- Nephrology Physician's LLC, Mishawaka
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/21更新 · NCT05485961A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
- Research Site, Evansville
- Research Site, Evansville
- Research Site, Indianapolis
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/24更新 · NCT07000357Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD
- American Health Network Research Dept, Muncie
- American Health Network Research Dept, Muncie
被験者募集中第3相
18歳〜80歳 · 全性別 · 2026/08/07更新 · NCT06813911Pharmacogenomic Informed Statin Prescribing
- Richard L. Roudebush VA Medical Center, Indianapolis, IN, Indianapolis
被験者募集中
40歳〜75歳 · 全性別 · 2026/04/13更新 · NCT06568601ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。